Group Says Asian Children With HIV/AIDS At Risk Of Drug-Resistance
This article was originally published in PharmAsia News
Although more Asians now have access to basic drugs for treating HIV/AIDS, children with the diseases are showing signs of early osteoporosis caused by their treatments, some as young as five years old becoming drug-resistant.
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.